Corporate Tech Investors

Merz Pharma

Merz Pharma is a corporate VC investing group that makes equity investment in technologies that align with its strategic interests.

Venture Investor Overview

Contact Information

Background Information

Overview

Merz Pharma is an independent international aesthetics and neurotoxin company with its own research and development capabilities. Our continued growth and market leadership in aesthetics and neurotoxins is the result of our drive for innovation, along with focused, strategic acquisitions. We have continued to expand across all areas of our business, due to a focused, purposeful approach that includes both organic and inorganic growth. As a privately-held and family-owned company with a 100 year-plus history, we believe in taking a long-term view.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

10/28/2024

Transaction History

Our records indicate that Merz Pharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Philip Burchard

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Merz Pharma has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

Merstal | Meta Farms

Share this article

About Our Corporate VC Database

Our corporate equity investment data comes from VentureDeal.com, a leading provider of corporate tech investing transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary